Rocket Pharmaceuticals investigational gene therapy for Pyruvate Kinase Deficiency
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rocket Pharmaceuticals investigational gene therapy for Pyruvate Kinase Deficiency, covering 2025-09-05 to 2025-09-05. Get the full timeline:
Most recent: Clinical Trial Update: Gene Therapy for Pyruvate Kinase Deficiency (PKD) [Phase 1]